ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
Articles
COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Beats Revenue for Q2 2024
COLL stock results show that Collegium Pharmaceutical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
CARG Stock Earnings: CarGurus Beats EPS, Beats Revenue for Q2 2024
CARG stock results show that CarGurus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
HHS Stock Earnings: Harte-Hanks Misses EPS, Misses Revenue for Q2 2024
HHS stock results show that Harte-Hanks missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
IDN Stock Earnings: Intellicheck Beats EPS, Misses Revenue for Q2 2024
IDN stock results show that Intellicheck beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
LODE Stock Earnings: Comstock Misses EPS, Misses Revenue for Q2 2024
LODE stock results show that Comstock missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
